Marta Weinstock-Rosin
Marta Weinstock-Rosin · Science & Medicine
Developed rivastigmine (Exelon), a leading drug for Alzheimer's and Parkinson's dementia, at the Hebrew University of Jerusalem.
1935, Vienna, Austria
Vienna, Austria
Marta Weinstock-Rosin is recognized among Israeli contributors to Science & Medicine — Developed rivastigmine (Exelon), a leading drug for Alzheimer's and Parkinson's dementia, at the Hebrew University of Jerusalem.
Marta Weinstock-Rosin is an Austrian-born Israeli neuropharmacologist. Born into a Jewish family in Vienna, she fled with her family to England in 1939 after her father was arrested by the Nazis, and later settled in Israel. At the Hebrew University of Jerusalem she developed rivastigmine (Exelon), one of the world's leading treatments for Alzheimer's disease and Parkinson's dementia, work for which she was awarded the Israel Prize.
Verify and go deeper with these external references.
Source: Wikipedia
Developed rivastigmine (Exelon), a leading drug for Alzheimer's and Parkinson's dementia, at the Hebrew University of Jerusalem.
Source: Wikipedia
